Keywords: UK, ABPI, PPRS, Price negotiations, Boehringer Ingelheim, Pradaxa, Code of Practice
UK ABPI gears up for next pricing negotiations; Boehringer breaches code
Article | 19 December 2011
The Association of the British Pharmaceutical Association (ABPI) last Friday brought together pharmaceutical industry leaders to gain a clearer understanding ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
